Results 101369 adults had a first-recorded code of breathlessness, of whom 66909 (66%) received and 34460 (34%) did not receive a diagnosis: mean (SD) age 57 (16) vs 49 (16) years, 38% vs 48% never ...

Introduction Better patient selection for non-invasive ventilation (NIV), and time to NIV initiation, are national improvement objectives.1Treatment escalation planning (TEP) was also identified ...

Introduction Clinical trials suggest attendance at PR reduces subsequent hospitalisation rates. However, whether this benefit occurs in routine clinical practice is uncertain. We analysed admission ...

Objective To evaluate the surgical outcomes following neoadjuvant chemo-immunotherapy and surgery for locally advanced non-small cell lung cancer. Methods Prospective analysis on all consecutive ...

A pillar of the WHO End TB Strategy is targeted latent tuberculosis infection (LTBI) testing to identify persons who would benefit from TB preventive treatment (TPT).1 The WHO recommends the ...

Background Idiopathic pulmonary fibrosis (IPF) is characterised by damage to the epithelial layer, closely associated with the alveolar basement membrane (BM). We aimed to investigate how type IV ...

Background We describe the epidemiology of asthma, chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) from 2004 to 2023 in England, Wales, Scotland and Northern Ireland ...

Rationale Telemonitoring has shown benefits during the initiation of home non-invasive ventilation (NIV) but evidence is lacking regarding its use during follow-up. A French national telemonitoring ...

Background Singing for Lung Health (SLH) is an arts-based non-pharmacological intervention for people with long-term respiratory conditions that aims to improve symptoms and quality of life (QOL).

We present the case of a 45-year-old man who reported 2 years of cough and expectoration and 1 year of dyspnoea. He had a history of dry nasal snuff inhalation 15 times/day for 10 years, worked as a ...

Pulmonary rehabilitation has established itself as a vital and core therapy for people with chronic lung disease. Significant improvements are seen in several patient outcomes, for the thousands ...